The topical ocular drug is an investigational new drug candidate that requires more well-controlled studies to establish ...

Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council, discusses the importance of clearly defining the role of patient representatives on pharmacy-and-therapeutics and ...

Dan Nardi, MS, CEO of Reimagine Care, claims that on-demand cancer treatment via telehealth is the future of oncology care delivery.

Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth, discusses strategies for managing costs of novel cellular and gene therapies in the oncology pipeline.

Jawad Haider Butt, MD, PhD, Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, United Kingdom.

Findings presented at the American College of Cardiology Annual Scientific Session indicate that finerenone's efficacy in ...

Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida, discusses gene therapy considerations for pediatric patients and how newborn screening can influence outcomes for ...

Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in ...

JC Scott, CEO and president of The Pharmaceutical Care Management Association, discusses the evolving role pharmacy benefit managers (PBMs) play in addressing payer, provider, and patient needs.

A bipartisan letter from lawmakers questions the legality of Robert F. Kennedy Jr's HHS changes and the lack of clear ...

As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for ...

Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those ...